General description
INN
Ampicillin
Medicine type
Chemical agent
EML status history
First added in 1977
(TRS
615)
for
Bacterial infection of unspecified site
Removed in 1989
(TRS
796)
for
Bacterial infection of unspecified site
Added in 2017
(TRS
1006)
for
Bacterial meningitis
Added in 2017
(TRS
1006)
for
Acute malnutrition in infants, children or adolescents
Added in 2017
(TRS
1006)
for
Sepsis without septic shock
Added in 2017
(TRS
1006)
for
Bacterial pneumonia
Added in 2017
(TRS
1006)
for
Sepsis without septic shock
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Access group antibiotics
- Oral > Liquid: 125 mg per 5 mL (anhydrous) powder for oral suspension
- Oral > Solid: 250 mg (anhydrous); 500 mg (anhydrous)
- Parenteral > General injections > unspecified: 500 mg in vial (as sodium salt) powder for injection; 1 g in vial (as sodium salt) powder for injection
Indications
First choice
co-prescribed with gentamicin Bacterial pneumonia (Severe) [children] co-prescribed with gentamicin Sepsis without septic shock co-prescribed with gentamicin Acute malnutrition in infants, children or adolescents (complicated) [children] co-prescribed with gentamicin Sepsis without septic shockSecond choice
Bacterial meningitis
Other indications